Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.
Saved in:
| Title: | Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study. |
|---|---|
| Authors: | Tut G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Lancaster T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Krutikov M; UCL Institute of Health Informatics, University College London, London, UK., Sylla P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Bone D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Kaur N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Spalkova E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Bentley C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Amin U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Jadir AT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Hulme S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Butler MS; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Ayodele M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Shrotri M; UCL Institute of Health Informatics, University College London, London, UK., Azmi B; UCL Institute of Health Informatics, University College London, London, UK., Fuller C; UCL Institute of Health Informatics, University College London, London, UK., Irwin-Singer A; Department of Health and Social Care, London, UK., Hayward A; Health Data Research UK, London, UK., Copas A; UCL Institute for Global Health, University College London, London, UK., Shallcross L; UCL Institute of Health Informatics, University College London, London, UK., Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. |
| Source: | The lancet. Healthy longevity [Lancet Healthy Longev] 2021 Sep; Vol. 2 (9), pp. e544-e553. Date of Electronic Publication: 2021 Aug 19. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101773309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-7568 (Electronic) Linking ISSN: 26667568 NLM ISO Abbreviation: Lancet Healthy Longev |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
